Skip to content

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL
SOHO EAGLE program takes off, expanding access to education globally
Dr. Shulman discusses US cancer surveillance challenges
New blood test diagnoses multiple myeloma noninvasively
Treatment post-relapse improves survival outcomes in patients with AML or MDS

Join SOHO

Follow Us :

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Cellular Therapy

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Leukemia

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Lymphoma

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Multiple Myeloma

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML or MDS

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

August 19, 2025

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Myelodysplastic Syndromes

MDS News

a globe

Acute Myeloid Leukemia Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML or MDS

by SOHO Insider Editors
August 11, 2025
0 Comments

SOHO Insider podcast

SOHO 2025 Meeting News Myelodysplastic Syndromes News SOHO Insider Podcast

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

by Leah Sherwood
July 23, 2025
0 Comments

cancer cells

Acute Myeloid Leukemia Myelodysplastic Syndromes News

Combo eprenetapopt plus azacitidine is well-tolerated in TP53-mutated MDS and AML

by SOHO Insider Editors
July 22, 2025
0 Comments

Organization structure, social network and teamwork concept on dark background. Business people icon on wooden cube blocks connecting network of connections.

Myelodysplastic Syndromes

Study identifies nonmutational p53 dysfunction as MDS risk factor

by Leah Sherwood
May 13, 2025
0 Comments

Green light

Myelodysplastic Syndromes

FDA grants Orphan Drug designation for bexmarilimab in MDS

by SOHO Insider Editors
May 12, 2025
0 Comments

European Commission

Myelodysplastic Syndromes

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

by Leah Sherwood
March 17, 2025
0 Comments

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Abstract submissions now open for SOHO 2025

by Leah Sherwood
February 14, 2025
0 Comments

Leukemia Myelodysplastic Syndromes News

Is unrelated cord blood better than bone marrow in haploidentical transplantation?

by SOHO Insider Editors
February 4, 2025
0 Comments

Myelodysplastic Syndromes

Dr. Garcia-Manero discusses mature data on luspatercept’s efficacy in MDS

by Leah Sherwood
January 22, 2025
0 Comments

fast track

Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes News

FDA grants fast track designation to LYT-200 in AML

by Leah Sherwood
January 17, 2025
0 Comments

1
2

Top Categories

Cellular Therapy

13

Leukemia

44

Lymphoma

50

Multiple Myeloma

42

Myelodysplastic Syndromes

16

Myeloproliferative Neoplasms

11

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Categories

FDA grants fast track designation to LYT-200 in AML

Cellular Therapy

FDA grants fast track designation to LYT-200 in AML

Leukemia

FDA grants fast track designation to LYT-200 in AML

Lymphoma

FDA grants fast track designation to LYT-200 in AML

Multiple Myeloma

FDA grants fast track designation to LYT-200 in AML

Myelodysplastic Syndromes

FDA grants fast track designation to LYT-200 in AML

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Submit

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

SOHO EAGLE program takes off, expanding access to education globally

Dr. Shulman discusses US cancer surveillance challenges

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.